Conmed (CNMD) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $49.25 -2.3%
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.42, $0.01 better than the analyst estimate of $0.41. Revenue for the quarter came in at $190.1 million versus the consensus estimate of $187.08 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Four Tree Island Advisory calls DoubleDown $11.25 offer too low
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
